The patentability of life forms, and specifically plants and animals, have remained contentious issues in several jurisdictions. Recently, the Supreme Court of Canada rejected the patentability of the Harvard Oncomouse in Canada, ruling that Canada’s Patent Act did not allow patents for higher life forms and it was up to the legislature to provide a proper legislative basis for such patents. Article 27.3(b) of the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement provides members with an option to exclude plants and animals from patentability. At the same time however, members are expected to provide for the protection of plant varieties either through patents or through an effective sui generis system or through any combination thereof. For example, the UPOV convention (The Convention for the Protection of New Varieties of Plants) provides plant breeders with limited monopoly rights to commercialize new plant varieties.